What is Nektar Therapeutics's common stock?

Nektar Therapeutics (NKTR) reported common stock of 390M in Q1 2026.

How has Nektar Therapeutics's common stock changed year-over-year?

Nektar Therapeutics's common stock increased by 30.0% year-over-year, from 300M to 390M.

What is the long-term trend for Nektar Therapeutics's common stock?

Over 5 years (2020 to 2025), Nektar Therapeutics's common stock has grown at a 636.5% compound annual growth rate (CAGR), from 18K to 390M.

What does common stock mean?

The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).

Nektar Therapeutics NKTR Common Stock

Common Stock at other companies

AmgenAMGN

2.8B0.0%

ImmunityBio, Inc.IBRX

1.7B+22.2%

Apogee Therapeutics, Inc.APGE

$1K0.0%

ImmunomeIMNM

$11K+22.2%

Iovance Biotherapeutics, Inc.IOVA

$18K+28.6%

Kymera TherapeuticsKYMR

$8K+14.3%

Other financials

Income statement

See full

Revenue$10.9M+3.8%

Gross profit$21.8M+2.9%

Operating income-$39.1M+12.3%

Net income-$44.9M+11.7%

EPS (diluted)-$1.82+49.7%

Balance sheet

See full

Cash & equivalents$5.7M-20.0%

Total debt$83.2M-17.1%

Total equity$576.2M+4,094%

Total assets$763.3M+198%

Cash flow

See full

Operating cash flow-$44.3M+9.7%

CapEx$18.0K+800%

Free cash flow-$44.3M+9.7%

Valuation

See full

Market cap$2.25B+1,531%

Enterprise value$2.33B+874%

P/S40.5×+38.9×

Profitability

See full

Gross margin100%+31.2pp

Operating margin-242%—

Net margin-284.2%+937pp

FCF margin-366.6%+1,421pp

Returns & leverage

See full

Return on equity-53.6%-22.6pp

Debt / equity0.1×-7.2×

Current ratio10.2×+7.0×

Where this comes from

Reported directly by Nektar Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: Nektar Therapeutics’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nektar Therapeutics's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Nektar Therapeutics's common stock?: Nektar Therapeutics (NKTR) reported common stock of 390M in Q1 2026.
How has Nektar Therapeutics's common stock changed year-over-year?: Nektar Therapeutics's common stock increased by 30.0% year-over-year, from 300M to 390M.
What is the long-term trend for Nektar Therapeutics's common stock?: Over 5 years (2020 to 2025), Nektar Therapeutics's common stock has grown at a 636.5% compound annual growth rate (CAGR), from 18K to 390M.
What does common stock mean?: The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).